KEVIN FIELD: Open Payments
NPI 1992435150 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 72 payments from 10 companies in 2025. Trend: 2023 $505 · 2024 $839 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $322 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $296 |
| ABBVIE INC. | 16 | $244 |
| Neurocrine BioSciences, Inc. | 5 | $205 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| JAZZ PHARMACEUTICALS INC. | 3 | $75 |
| Janssen Pharmaceuticals, Inc | 4 | $63 |
| Lundbeck LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: CAPLYTA, UZEDY, VRAYLAR, INGREZZA, REXULTI, XYWAV, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across NM — which companies pay providers there.
